SCHEMBL9696231

SCHEMBL9696231

CC(C)c1c(CCCO[PH](=O)C[C@@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2n1CCCC2

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 13/20 0.37
NR1I2 O75469 1/20 0.34
ABCB11 O95342 1/20 0.34
RHOC P08134 1/20 0.34
CYP3A4 P08684 1/20 0.34
THRB P10828 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
NR1H4 Q96RI1 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
ESR1 P03372 1/20 0.33
CHRM1 P11229 1/20 0.33
TBXA2R P21731 1/20 0.33
PDE4A P27815 1/20 0.33
ADRA1A P35348 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696237 1.00 HMGCR (0.37) HMGCRNR1I2ABCB11RHOCCYP3A4
SCHEMBL9696603 0.85 KMT2A (0.38) HMGCR
SCHEMBL9696597 0.85 KMT2A (0.38) HMGCR
SCHEMBL9695389 0.82 HMGCR (0.37) HMGCRNR1I2ABCB11RHOCCYP3A4
SCHEMBL9696722 0.82 HMGCR (0.37) HMGCRNR1I2ABCB11RHOCCYP3A4
SCHEMBL9696224 0.79 HMGCR (0.38) HMGCRNR1I2ABCB11RHOCCYP3A4
SCHEMBL9696147 0.79 HMGCR (0.39) HMGCRNR1I2ABCB11RHOCCYP3A4
SCHEMBL9696156 0.79 HMGCR (0.39) HMGCRNR1I2ABCB11RHOCCYP3A4
SCHEMBL9697134 0.74 KMT2A (0.39) HMGCR
SCHEMBL6944860 0.73 HMGCR (0.42) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5124453-A Treatment of corresponding aldehyde with lithium bis(tri-methylsilyl)amide E. R. SQUIBB & SONS, INC. (US) 1992-06-23 US disclosed
EP-0444532-A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method E.R. SQUIBB & SONS, INC. (US) 1991-09-04 EP disclosed
US-5025000-A Anticholesterol, antilipemic agents E. R. SQUIBB & SONS, INC. (US) 1991-06-18 US disclosed